This shouldn’t be a priority for the Oregon Health Authority, particularly amid a pandemic with no clear end in sight… …the measure [estimated to cost over 6 million dollars during the next two years], if passed, would give the Oregon Health Authority two years to work with [a self-appointed] advisory board in developing the regulatory…
Field Trip [Oregon Measure 109 donor] went public through a direct listing on the Canadian Securities Exchange after it completed a reverse takeover of oil and gas company Newton Energy Corporation. Field Trip, which is not profitable and incurred a net loss of $2 million, has a three-pronged approach to the psychedelics market – treatment…
I cannot support Measure 109 for the following reasons… there are two different ballot measures this fall that would change state law (and only state law) regarding the possession and use of psilocin – the active ingredient in “magic” psilocybin mushrooms. The proponents of Measure 109 are focused on setting up specialty facilities and services…
Passing Measure 109, she said, would “set up Oregonians as really the guinea pigs to be receiving psilocybin treatment for psychological conditions with high rates of morbidity and mortality if treated quickly or left untreated.” The leader of the Oregon Psychiatric Physician Association told The Lund Report the group opposes the measure, as does American…
…no stranger to the psychedelic scene having collaborated with Timothy Leary, Robert Anton Wilson, Terence McKenna, Ralph Metzner, Mark Pesce, and Erik Davis. …the mental health epidemic as an externality of capitalism, and placing our trust in… cures [that generate profits at the expense of individual and natural rights]. Will [the current pandemic] be to…
To date, much of the clinical research on psychedelics has focused on their potential to treat acute mental health conditions, such as treatment-resistant depression. But scientists are also examining the drugs’ effects on so-called “healthy normal” populations — in other words, people who haven’t been diagnosed with an addiction or mental illness. In one 2018…
A healthcare investment firm that’s backing studies of “magic mushrooms” to treat depression raised $25m of capital… …already in talks with banks about a potential listing in Canada next year, a step for which it seeks a valuation of $800m or more, according to one of the people familiar with the matter. After being shunned…
The relative safety of magic mushrooms, when compared to other drugs, is incredibly high. Psilocybin comes in last place when you rank drugs in terms of their harm to the individual or society at large. He also explained that the abuse potential for psilocybin is low. “No one is jonesing for their next [dose of]…
“While psychedelic drugs rose to prominence in the 1960s, the attendees at an Ashland conference say the nation and world would be a better place if the non-addictive drugs regained their footing in society.” The “peace and love” message of the ’60s — inspired in part by psychedelic drugs — hasn’t changed over the last…
Recent Comments